Latest Insider Transactions at Elevance Health, Inc. (ELV)
This section provides a real-time view of insider transactions for Elevance Health, Inc. (ELV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Elevance Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Elevance Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2023
|
Mark Kaye EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,276
+29.7%
|
-
|
|
Jul 21
2023
|
Robert L Dixon Jr Director |
SELL
Open market or private sale
|
Direct |
310
-3.12%
|
$147,560
$476.71 P/Share
|
|
May 10
2023
|
Lewis Hay Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+4.16%
|
-
|
|
May 10
2023
|
Ramiro G Peru Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+4.43%
|
-
|
|
May 10
2023
|
Antonio F Neri Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+10.4%
|
-
|
|
May 10
2023
|
Robert L Dixon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+4.39%
|
-
|
|
May 10
2023
|
Elizabeth E Tallett Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+4.41%
|
-
|
|
May 10
2023
|
Bahija Jallal Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+10.74%
|
-
|
|
May 10
2023
|
Ryan M. Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+7.53%
|
-
|
|
May 10
2023
|
R Kerry Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+5.02%
|
-
|
|
May 10
2023
|
Deanna D Strable Soethout Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+41.02%
|
-
|
|
May 10
2023
|
Susan D. De Vore Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+25.82%
|
-
|
|
Mar 24
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Open market or private sale
|
Direct |
15,098
-4.15%
|
$6,688,414
$443.63 P/Share
|
|
Mar 09
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
2,314
-13.12%
|
$1,069,068
$462.22 P/Share
|
|
Mar 02
2023
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
380
-11.65%
|
$177,840
$468.78 P/Share
|
|
Mar 02
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-5.79%
|
$507,312
$468.78 P/Share
|
|
Mar 02
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
5,430
-7.55%
|
$2,541,240
$468.78 P/Share
|
|
Mar 02
2023
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-12.45%
|
$2,224,872
$468.78 P/Share
|
|
Mar 02
2023
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,650
-6.8%
|
$2,176,200
$468.78 P/Share
|
|
Mar 02
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
5,469
-23.41%
|
$2,559,492
$468.78 P/Share
|
|
Mar 02
2023
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,614
-11.48%
|
$8,243,352
$468.78 P/Share
|
|
Mar 01
2023
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,717
+17.25%
|
-
|
|
Mar 01
2023
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-4.49%
|
$174,468
$469.03 P/Share
|
|
Mar 01
2023
|
Ronald W Penczek CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+18.1%
|
-
|
|
Mar 01
2023
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
64
-3.34%
|
$30,016
$469.03 P/Share
|
|
Mar 01
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
4,568
+11.54%
|
-
|
|
Mar 01
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-2.03%
|
$137,417
$469.03 P/Share
|
|
Mar 01
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
BUY
Grant, award, or other acquisition
|
Direct |
11,849
+7.6%
|
-
|
|
Mar 01
2023
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
617
-1.02%
|
$289,373
$469.03 P/Share
|
|
Mar 01
2023
|
Felicia F Norwood EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct |
12,008
+13.86%
|
-
|
|
Mar 01
2023
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
495
-1.86%
|
$232,155
$469.03 P/Share
|
|
Mar 01
2023
|
John E Gallina EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,781
+8.7%
|
-
|
|
Mar 01
2023
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
587
-1.04%
|
$275,303
$469.03 P/Share
|
|
Mar 01
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
12,008
+21.88%
|
-
|
|
Mar 01
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
607
-5.07%
|
$284,683
$469.03 P/Share
|
|
Mar 01
2023
|
Gail Boudreaux President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,297
+12.81%
|
-
|
|
Mar 01
2023
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,471
-2.21%
|
$1,158,899
$469.03 P/Share
|
|
Jan 03
2023
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,983
+32.47%
|
-
|
|
Dec 30
2022
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
1,754
-6.17%
|
$898,048
$512.97 P/Share
|
|
Dec 01
2022
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-2.65%
|
$61,425
$525.25 P/Share
|
|
Nov 04
2022
|
Gail Boudreaux President and CEO |
SELL
Bona fide gift
|
Direct |
10,000
-8.24%
|
-
|
|
Nov 01
2022
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
200
-1.64%
|
$108,800
$544.53 P/Share
|
|
Nov 01
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-0.54%
|
$42,976
$544.53 P/Share
|
|
Nov 01
2022
|
Deanna D Strable Soethout Director |
BUY
Grant, award, or other acquisition
|
Direct |
200
+50.0%
|
-
|
|
Jun 09
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
6,328
-6.86%
|
$3,094,392
$489.56 P/Share
|
|
Jun 09
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
6,328
+7.66%
|
$1,771,840
$280.62 P/Share
|
|
Jun 06
2022
|
Robert L Dixon Jr Director |
SELL
Open market or private sale
|
Direct |
420
-4.24%
|
$208,740
$497.14 P/Share
|
|
May 19
2022
|
Ramiro G Peru Director |
SELL
Open market or private sale
|
Direct |
990
-9.52%
|
$463,320
$468.88 P/Share
|
|
May 18
2022
|
Robert L Dixon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+4.25%
|
-
|
|
May 18
2022
|
Bahija Jallal Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+11.63%
|
-
|